Pittvax

Researchers at the University of Chicago Medicine and the Icahn School of Medicine at Mt. Sinai Hospital in New York City found that utilizing neuraminidase-reactive antibodies showed comparable effectiveness to that of hemagglutinin-reactive antibodies. Thus, vaccines that stimulate neuraminidase antibodies instead of only focusing on hemagglutinin, are likely to be more effective than current vaccines. Read more here.

For a better influenza vaccine, focus on the neglected 'N' In the April 5, 2018, issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase. For decades, flu vaccines have concentrated on hemagglutinin. The authors maintain that a focus on neuraminidase could lower infection rates and less...

The PittVax Research team at the University of Pittsburgh Department of Family Medicine contributed to a recently published study that found that immunization rates significantly decreased when the needle-less vaccine was not offered. The nasal spray live attenuated influenza vaccine, or LAIV had been offered until the 2016-2017 influenza season when the CDC recommended that it not be used due to low vaccine effectiveness. Read more here.

https://www.ncbi.nlm.nih.gov/pubmed/28431811

Potential Consequences of Not Using Live Attenuated Influenza Vaccine. - PubMed - NCBI Am J Prev Med. 2017 Apr 18. pii: S0749-3797(17)30170-8. doi: 10.1016/j.amepre.2017.02.019. [Epub ahead of print]